S-1/A: CONX Corp Files Amendment No. 2 to Form S-1, Registers Shares for Warrant Exercise and Resale

CONX Corp has filed an amendment to its Form S-1 registration statement to register shares of Class A common stock issuable upon warrant exercise and for resale by selling securityholders.

Summary

• CONX Corp has filed an Amendment No. 2 to Form S-1 to register 30,083,285 shares of Class A Common Stock issuable upon exercise of warrants and 30,000 shares for resale by selling securityholders.
• The company will receive proceeds of up to $346.0 million if all warrants are exercised for cash, but will not receive any proceeds from the sale of shares by the selling securityholders.
• The exercise price for each warrant is $11.50 per share.
• As of July 23, 2024, the closing price of CONX's Class A Common Stock was $4.00, and the closing price for the Public Warrants was $0.07.
• The company believes warrant holders are unlikely to exercise their warrants if the stock price remains below $11.50.
• Private Placement Warrants may be exercised on a cashless basis by nXgen Opportunities LLC or its permitted transferees.
• The registration of these shares creates the possibility of a significant increase in the supply of Class A Common Stock in the market and of substantial dilution, which could result in a significant decline in the public trading price of our securities due to our limited public float.
• Charles W. Ergen, through nXgen, beneficially owns approximately 99.4% of CONX's Class A Common Stock and may exert substantial influence on stockholder votes.
• The company's Class A Common Stock and Public Warrants are traded on the OTCQX Market under the symbols CNXX and CNXXW, respectively.
• The company completed its business combination on May 1, 2024, acquiring a commercial real estate property in Littleton, Colorado, for $26.75 million.

Sentiment

Score: 4

Explanation: The document presents a mixed picture. While the potential for warrant exercise provides a possible capital infusion, the low stock price, potential dilution, and Nasdaq delisting create significant risks and uncertainties.

Positives

• The company could receive up to $346.0 million if all warrants are exercised for cash.
• The company completed its business combination on May 1, 2024, acquiring a commercial real estate property in Littleton, Colorado, for $26.75 million.

Negatives

• The company believes warrant holders are unlikely to exercise their warrants if the stock price remains below $11.50.
• The registration of these shares creates the possibility of a significant increase in the supply of Class A Common Stock in the market and of substantial dilution, which could result in a significant decline in the public trading price of our securities due to our limited public float.
• Charles W. Ergen, through nXgen, beneficially owns approximately 99.4% of CONX's Class A Common Stock and may exert substantial influence on stockholder votes.

Risks

• The company's success depends on a single tenant for substantially all of its revenues.
• The company may face litigation and rising liability and insurance costs.
• The company has limited experience in operating commercial real estate.
• The company has not been profitable historically and may not achieve or maintain profitability in the future.
• The company's securities have been delisted from Nasdaq, which has limited investors' ability to make transactions in its securities.
• The company has a relatively limited number of shares of Class A Common Stock outstanding, 99.4% of which is held by nXgen, which could result in continued volatility of its stock price.

Future Outlook

The company anticipates growing through further acquisition opportunities, including disruptive technologies and infrastructure assets, and may seek to take meaningful equity ownership stakes in operating companies.

Industry Context

The document relates to the financial mechanics of a special purpose acquisition company (SPAC) post-business combination, specifically the registration of shares for warrant exercise and resale. This is a common process for SPACs after they have identified and merged with a target company.

Comparison to Industry Standards

• The structure of the warrant agreement, including the exercise price and redemption triggers, is typical for SPACs.
• The influence of a controlling shareholder like Charles W. Ergen is not uncommon in SPACs, but it does present potential conflicts of interest.
• The delisting from Nasdaq and subsequent trading on the OTCQX Market is a negative development, as it typically reduces liquidity and investor confidence.
• Comparable companies in the SPAC space include Digital World Acquisition Corp. (DWAC) and Churchill Capital Corp IV (CCIV), which have also experienced significant volatility and challenges post-merger.

Related Party Transactions

• Charles W. Ergen, through nXgen, beneficially owns approximately 99.4% of CONX's Class A Common Stock and may exert substantial influence on stockholder votes.
• Private Placement Warrants may be exercised on a cashless basis by nXgen Opportunities LLC or its permitted transferees.

Stakeholder Impact

• Existing stockholders may experience dilution if warrants are exercised.
• Public securityholders may not be able to experience the same positive rates of return on securities they purchase because the Independent Directors received shares of Class A Common Stock at no cost.
• The registration of these shares creates the possibility of a significant increase in the supply of Class A Common Stock in the market and of substantial dilution, which could result in a significant decline in the public trading price of our securities due to our limited public float.

Next Steps

• The company will use commercially reasonable efforts to maintain the effectiveness of the registration statement for the Class A Common Stock issuable upon exercise of the warrants.
• The company may redeem the Public Warrants under certain conditions.

Key Dates

Keywords

Class A Common Stock, Warrants, CONX Corp, Registration Statement, Selling Securityholders, Private Placement, Business Combination, Equity Forward, OTC Markets, Delisting